Global Clinical Trials | Pretoria, South Africa
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
An open-label, single-arm clinical trial to confirm the safety of monoarticular injections or bi-lateral intra-articular injections of RTX-GRT7039 in patients who have pain associated with osteoarthritis of the knee despite standard of care.
Full description
This trial comprises a total observation period of up to 78 weeks.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
The non-index knee is not eligible for treatment in the trial, if any of the knee-related exclusion criteria applies to the non-index knee.
Primary purpose
Allocation
Interventional model
Masking
930 participants in 1 patient group
Loading...
Central trial contact
Director clinical trials
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal